A questionnaire based study-assessment of knowledge, attitude and practice of pharmacovigilance among health care professionals, pre and post educational intervention

Husna Fatima, Ghulam Subhani, Mohammed Mohsin, D. Nageswari Devi


Background: Pharmacovigilance (PV) is an important tool in generating adverse drug reaction (ADR) data. However, the practice of PV is still very low among health care professionals due to lack of knowledge and awareness. This study was conducted to assess the level of  knowledge, awareness and practice of PV among health care professionals and to assess subsequent change in these after PV training session.

Methods: A cross sectional questionnaire based study was conducted among health care professionals of a tertiary health care and teaching institute. Participants were given a questionnaire. They completed it before and after undergoing training programme in PV. Impact of effectiveness of educational intervention (continuing medical education-CME (pharmacovigilance workshop) was evaluated by paired t-test.

Results: Out of 110 participants, 96 participants completely filled the questionnaire before and after the educational intervention (CME). CME on PV was found to increase knowledge and positive attitudes towards various aspects of PV.

Conclusions: Training programme on PV will help increase the knowledge as well as awareness about principles and techniques of PV and improve the rate of spontaneous ADR reporting. Organising frequent CME programmes and workshops will increase the credibility of health care in the country.



Pharmacovigilance, Awareness, Adverse drug reactions, Knowledge, Practice

Full Text:



WHO. Fact sheet: Regulation and prequalification, 2016. Available at: areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed on 11 March 2021. fact sheet: Adverse drug reactions database, 2016. Available at: http://www.adrdatabase. com/What%20are%20ADRshtml#Definition. Accessed on 11 March 2021.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5.

Pirmohamed M. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329(7456):15-9.

Ayani I, Aguirre C, Gutiérrez G, Madariaga A, Rodríguez-Sasiaín J, Martínez-Bengoechea M. A cost-analysis of suspected adverse drug reactions in a hospital emergency ward. Pharmacoepidemiol Drug Safety. 1999;8(7):529-34.

Lopez-Gonzalez E, Herdeiro M, Figueiras A. Determinants of under-reporting of adverse drug reactions. drug safety. 2009;32(1):19-31.

Feely J, Moriarty S, O'Connor P. Stimulating reporting of adverse drug reactions by using a fee. BMJ. 1990;300(6716):22-3.

Prakash S. Pharmacovigilance in India. Indian J Pharmacol. 2007;39(4):123-3.

Gupta YK. Ensuring patient safety-launching the new pharmacovigilance programme of India. Pharma Times. 2010;42:21-6.

ISPOR India. Fact sheet: Pharmacovigilance programme of india (PvPI). ISPOR India, 2013. Available at: Accessed on 11 March 2021.

Inman WH. The attitudes to the adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5):433-5.

Praveen S, Prakash RJ, Manjunath GN, Gautham MS, Kumar N. Adverse drug reaction reporting among medical and dental practitioners: a KAP study. Indian J Med Specialities. 2013;4:10-5.

Palaian S, Ibrahim MI, Mishra P. Health professionals knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract. 2011;9(4):228-35.

Ramesh M, Parthasarathi G. Adverse drug reactions reporting: Attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res. 2009;2(2):10-4.

Hema NG, Bhuvana KB, Sangeetha. Pharmacovigilance: the extend of awareness among the final year students, interns and postgraduates in a government teaching hospital. J Clin Diagn Res. 2012;6(7):1248-53.

Praveen S, Prakash RJ, Manjunath GN, Gautham MS, Kumar N. Adverse drug reaction reporting among medical and dental practitioners: A KAP study. Indian J Med Specialities. 2013;4:10-5.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-36.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions among resident doctors. J Pharm Sci Res. 2011;3(2):1064-9.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: an observational study. J Nat Sci Biol Med. 2013;4(1):191-6.

Hanafi S, Torkamandi H, Hayatshahi A, Gholami K, Javadi M. Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting. Iran J Nurs Midwifery Res 2012;17(1):21-5.

Hardeep, Bajaj JK, Kumar R. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in Northern India. J Clin Diagn Res. 2013;7(1):97-9.

Karelia BN, Piparava KG. Knowledge, attitude and practice of pharmacovigilance among private healthcare professionals of Rajkot city. Int J Basic Clin Pharmacol. 2014;3(1):50-3.

Bagewadi HG, Rekha MS, Anand SJ. A comparative evaluation of different teaching aids among fourth term medical students to improve the knowledge, attitude and perceptions about pharmacovigilance: an experimental study. Int J Pharm Res. 2015;5(4):91-7.

Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.